Myers

AstraZeneca shares were slumping while Bristol-Myers Squibb’s stock was jumping on Monday on reported deal talks. But the big question is why these two pharmaceutical giants would want to come…

Key events include direct-to-consumer drug platform launches tied to the Trump family, court rulings against Novo Nordisk over Medicare negotiations, a massive jury award against Johnson & Johnson, UnitedHealth acquiring…

Notable healthcare headlines for the week: Bristol Myers Squibb, Novo Nordisk and Sanofi in focus

Notable healthcare headlines for the week: AstraZeneca, Eli Lilly, Bristol Myers in focus